title: China national lung cancer screening guideline with low-dose computed tomography (2015 version).
abstract: BACKGROUND
  Lung cancer is the leading cause of cancer-related death in China. Results from a randomized controlled trial using annual low-dose computed tomography (LDCT) in specific high-risk groups demonstrated a 20% reduction in lung cancer mortality.
  
  
  METHODS
  A China national lung cancer screening guideline was developed by lung cancer early detection and treatment expert group appointed by the National Health and Family Planning Commission, based on results of the National Lung Screening Trial, systematic review of evidence related to LDCT screening, and protocol of lung cancer screening program conducted in rural China.
  
  
  RESULTS
  Annual lung cancer screening with LDCT is recommended for high risk individuals aged 50-74 years who have at least a 20 pack-year smoking history and who currently smoke or have quit within the past five years. Individualized decision making should be conducted before LDCT screening. LDCT screening also represents an opportunity to educate patients as to the health risks of smoking; thus, education should be integrated into the screening process in order to assist smoking cessation.
  
  
  CONCLUSIONS
  A lung cancer screening guideline is provided for the high-risk population in China.
authors.affiliation: Lung Cancer Center/Lung Cancer Institute, West China Hospital, Sichuan University Chengdu, China ; Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital Tianjin, China.
authors.forename: Qing-Hua
authors.initials: QH
authors.lastname: Zhou
authors.affiliation: Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital Tianjin, China.
authors.forename: Ya-Guang
authors.initials: YG
authors.lastname: Fan
authors.affiliation: Lung Cancer Center/Lung Cancer Institute, West China Hospital, Sichuan University Chengdu, China ; Department of Pathology, West China Hospital, Sichuan University Chengdu, China.
authors.forename: Hong
authors.initials: H
authors.lastname: Bu
authors.affiliation: Department of Radiology, Tianjin Medical University General Hospital Tianjin, China.
authors.forename: Ying
authors.initials: Y
authors.lastname: Wang
authors.affiliation: Department of Diagnostic Radiology, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College Beijing, China.
authors.forename: Ning
authors.initials: N
authors.lastname: Wu
authors.affiliation: Department of Thoracic Cardiovascular Surgery, the Third Affiliated Hospital of Kunming Medical College (Yunnan Tumor Hospital) Kunming, China.
authors.forename: Yun-Chao
authors.initials: YC
authors.lastname: Huang
authors.affiliation: Department of Endoscopy, Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College Beijing, China.
authors.forename: Guiqi
authors.initials: G
authors.lastname: Wang
authors.affiliation: Department of Pathology, Tianjin Medical University General Hospital Tianjin, China.
authors.forename: Xin-Yun
authors.initials: XY
authors.lastname: Wang
authors.affiliation: Department of Cancer Epidemiology, Cancer Institute, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, China.
authors.forename: You-Lin
authors.initials: YL
authors.lastname: Qiao
keywords: China; low-dose computed tomography; lung cancer screening guideline